Argonaut Capital Management’s Gilead Sciences GILD Stock Holding History

Argonaut Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.66M	Hold	16,900	–	–	5.57%	3
2015 Q2	$1.98M	Hold	16,900	–	–	5.72%	4
2015 Q1	$1.66M	Hold	16,900	–	–	2.67%	9
2014 Q4	$1.59M	Buy	16,900 +2,900	+21%	+$300K	2.3%	9
2014 Q3	$1.49M	Hold	14,000	–	–	2.02%	9
2014 Q2	$1.16M	Hold	14,000	–	–	1.25%	13
2014 Q1	$992K	Buy	+14,000	New	+$1.1M	0.67%	12

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Argonaut Capital Management's GILD Position: Q3 2015 in Review

Argonaut Capital Management held its Gilead Sciences (GILD) position steady in Q3 2015 at 16,900 shares worth $1.66M. The position accounts for 5.57% of the portfolio, ranked #3.

Argonaut Capital Management first reported a position in GILD in Q1 2014 and has held it in 7 quarters since. The position peaked at $1.98M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Argonaut Capital Management held 16,900 shares of Gilead Sciences worth $1.66M as of Q3 2015.
Argonaut Capital Management left its Gilead Sciences share count unchanged in Q3 2015.
Gilead Sciences made up 5.57% of Argonaut Capital Management's portfolio in Q3 2015, its #3 holding.
Argonaut Capital Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 7 quarters since.
Argonaut Capital Management's Gilead Sciences position peaked at $1.98M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Argonaut Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.